SARS-CoV-2-IN-33 is a small molecule inhibitor with dual research applications. It demonstrates binding affinity for the SARS-CoV-2 main protease (Mpro, PDB: 6LU7) and exhibits anti-proliferative activity in cancer cell studies, making it a compound for investigating both COVID-19 and oncology.
Molecular Weight:
526.58
CAS Number:
[299919-79-2]
Formula:
C30H30N4O5
Target:
Others,SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted